Insider Selling: Chemed Co. (NYSE:CHE) CEO Sells $1,197,620.00 in Stock

Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the transaction, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Chemed Trading Down 0.2 %

CHE opened at $599.04 on Monday. The stock’s 50 day simple moving average is $574.54 and its 200-day simple moving average is $575.46. The stock has a market cap of $9.07 billion, a PE ratio of 32.24, a P/E/G ratio of 2.40 and a beta of 0.44. Chemed Co. has a 1 year low of $497.36 and a 1 year high of $654.62.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the firm earned $4.71 EPS. Equities analysts forecast that Chemed Co. will post 21.77 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio is 10.76%.

Institutional Investors Weigh In On Chemed

Institutional investors have recently added to or reduced their stakes in the stock. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Chemed in the 1st quarter valued at $1,064,000. ProShare Advisors LLC grew its holdings in shares of Chemed by 6,288.9% in the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares during the last quarter. Cim LLC bought a new stake in shares of Chemed in the 4th quarter worth about $1,328,000. Sei Investments Co. increased its position in shares of Chemed by 4.5% during the 1st quarter. Sei Investments Co. now owns 41,336 shares of the company’s stock worth $26,535,000 after purchasing an additional 1,780 shares in the last quarter. Finally, American National Bank & Trust Co. VA acquired a new position in Chemed in the first quarter valued at about $3,122,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.